US Supreme Court Rules in Favor of Bayer in Landmark Roundup Cancer Lawsuit

13:00 - 26.06.2026


June 26, Fineko/abc.az. The United States Supreme Court has delivered a major legal victory for German pharmaceutical and agricultural conglomerate Bayer, ruling in favor of its subsidiary Monsanto in a long-standing lawsuit alleging that the glyphosate-based weedkiller "Roundup" causes cancer.

According to ABC.AZ, in a definitive 7-to-2 decision, the nation's highest court overturned a lower court's ruling against the company, establishing a massive legal shield for the corporate giant against systemic multi-billion dollar liability risks.

Core Structural and Legal Parameters of the Supreme Court Ruling:

  • Federal Preemption Primacy: The Court ruled that the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) preempts state-law claims based on an alleged "failure to warn." Since the US Environmental Protection Agency (EPA) explicitly determined that a cancer warning label is not required for the product, individual state courts cannot impose extra labeling burdens that conflict with federal regulatory mandates.

  • The Case Anchor: The decision stems from a lawsuit filed by John Durnell, who claimed that using Roundup for 20 years caused his illness. A Missouri state jury had previously awarded Durnell $1.25 million in damages—a judgment now completely voided by the Supreme Court.

In an official statement, Bayer described the ruling as a monumental breakthrough for science, farmers, and standard regulatory predictability across the broader biotech sector. The corporation indicated that this judicial precedent will structurally curtail the volume of ongoing Roundup litigation spanning nearly a decade and block future failure-to-warn claims. Notably, after acquiring Monsanto for $63 billion in 2018, Bayer faced a wave of mass tort lawsuits, prompting the company to announce a massive $7.25 billion settlement framework in February to resolve current and future claims.